RecruitingNot ApplicableNCT06756646

Exploring the Effects of Aerobic Exercise Combined with BFRT on Patients with COPD

Exploring the Effects of Aerobic Exercise Combined with Blood Flow Restriction Training on Exercise Capacity, Cardiopulmonary Functions, and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease


Sponsor

National Cheng Kung University

Enrollment

90 participants

Start Date

Nov 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in COPD patients.


Eligibility

Min Age: 30 YearsMax Age: 85 Years

Inclusion Criteria4

  • COPD classified as levels 2-4.
  • Stable condition without worsening in the past three months.
  • No participation in any rehabilitation program within the past six months.
  • Ability to understand and follow verbal commands and cooperate with an exercise training program.

Exclusion Criteria5

  • Unconscious or unable to cooperate with the evaluator.
  • Hospitalization due to acute illness within the past three months.
  • Severe joint diseases or history of lower limb surgery.
  • Severe cardiovascular disease (e.g., presence of a cardiac pacemaker or acute myocardial infarction within the past six months).
  • Dependence on oxygen supply.

Interventions

BEHAVIORALAerobic exercise intervention

The aerobic exercise intervention will utilize an ergometer. The program will be conducted 2-3 times per week over a 3-month period.

BEHAVIORALDisease and exercise suggestion

The participants will be provided by educational program about COPD self-care and home-based exercise approach.

BEHAVIORALBlood flow restriction (BFR) intervention

Blood flow restriction (BFR) intervention will combine aerobic exercise on the ergometer with BFR training. The program will be conducted 2-3 times per week over a 3-month period.


Locations(1)

National Cheng Kung University Hostipal

Tainan, Taiwan, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06756646


Related Trials